Interview | Ryan Guterman, CEO and Founder at FaradaIC Sensors GmbH
Be prepared to learn new things constantly
MoreInterview | Prof. Dr. Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens (MPUSP)
"Basic research is the basis for innovation"
MoreInterview | Prof. Dr. Petra Ritter, Head of TEF-Health and Dr. Dirk Schlesinger, Head of TÜV AI Lab
“Ultimately, the goal is to bring health-innovations Made in Europe to the marketplace.”
MoreInterview | Prof. Dr. rer. nat. Heyo K. Kroemer, Chief Executive Officer of Charité – Universitätsmedizin Berlin
Diverse challenges and opportunities
MoreInterview | BERLIN-CHEMIE: A woman heading the German business
Christiane von der Eltz was appointed to the Executive Board of BERLIN-CHEMIE on June 1 of this year and is responsible for the Pharma Germany division. The qualified pharmacist brings with her a wealth of experience in the pharmaceutical industry.…
MoreMore than the cheese of the future – Formo wants to create sustainability with biotech
The start-up Formo is a food biotech company that uses biotechnological processes to develop proteins for the food of the future. We spoke to Sandra Wilde, Formo’s Head of Food Science, about the current development status of the company and their…
MoreReplace, Reduce, Refine – More ethics in animal testing for tomorrow’s medicine
Interview with: Prof. Jens Kurreck, TU Berlin and Director of the 3R Center Berlin
MoreInterview with: Prof. Georg N. Duda and Bianca Lemke, Charité and cooperation partner Dr. Lutz Kloke, Cellbricks
Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…
MoreDr. Lutz Hilbrich, Chief Executive Officer at ProBioGen (and the subsidiary MiGenTra) and Andrea Hauptmann, Chief Financial Officer at ProBioGen (and the subsidiary MiGenTra)
ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…
MoreInterview with Jasper Emeis, research associate of the GrOwnValve project
GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…
MoreShow more items
